Myovant Sciences Profit Margin

The latest profit margin for MYOV is -48.47% as of December 2022. That compares with -115.18% in the prior-year period — up 57.9% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Myovant Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, MYOV's profit margin moved from -115.18% to -48.47% — a 57.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Myovant Sciences's valuation or profitability profile.

Against Healthcare companies, MYOV currently prints -48.47% for profit margin, while the sector average sits near 14.34%. That is roughly 437.9% below the sector mean. Large gaps often invite a closer look at Myovant Sciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Myovant Sciences converts resources into returns. At -48.47%, MYOV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -115.18% in the prior-year period — up 57.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MYOV's profit margin (-48.47%), review year-over-year change from -115.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.